Literature DB >> 31598574

Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma Sharing the PCM1-JAK2 Fusion and a Common T-Cell Clone.

Gregory M Riedlinger1, Aleksander Chojecki1,2, Hana Aviv1, David Weissmann1, Sonali Joshi1, Susan M Murphy1, Kim M Hirshfield1,3, Shridar Ganesan1.   

Abstract

Entities:  

Year:  2019        PMID： 31598574      PMCID： PMC6785048          DOI： 10.1200/PO.19.00082

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  17 in total

1.  Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classic Hodgkin disease.

Authors:  V Seitz; M Hummel; T Marafioti; I Anagnostopoulos; C Assaf; H Stein
Journal:  Blood       Date:  2000-05-15       Impact factor: 22.113

2.  Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classical Hodgkin's disease provides further evidence for its B-cell origin.

Authors:  H D Foss; R Reusch; G Demel; G Lenz; I Anagnostopoulos; M Hummel; H Stein
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

3.  Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.

Authors:  Guilin Tang; John Kennedy Sydney Sir Philip; Olga Weinberg; Wayne Tam; Sam Sadigh; Jonathan I Lake; Elizabeth M Margolskee; Heesun J Rogers; Roberto N Miranda; Carlos Bueso-Ramos C; Eric D Hsi; Attilio Orazi; Robert P Hasserjian; Daniel A Arber; Adam Bagg; Sa A Wang
Journal:  Mod Pathol       Date:  2018-11-06       Impact factor: 7.842

4.  JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma.

Authors:  Katrien Van Roosbroeck; Luk Cox; Thomas Tousseyn; Idoya Lahortiga; Olga Gielen; Barbara Cauwelier; Pascale De Paepe; Gregor Verhoef; Peter Marynen; Peter Vandenberghe; Chris De Wolf-Peeters; Jan Cools; Iwona Wlodarska
Journal:  Blood       Date:  2011-02-15       Impact factor: 22.113

5.  The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2.

Authors:  Andreas Reiter; Christoph Walz; Ann Watmore; Claudia Schoch; Ilona Blau; Brigitte Schlegelberger; Ute Berger; Nick Telford; Shilani Aruliah; John A Yin; Danny Vanstraelen; Helen F Barker; Peter C Taylor; Aisling O'Driscoll; Fabio Benedetti; Cornelia Rudolph; Hans-Jochem Kolb; Andreas Hochhaus; Rüdiger Hehlmann; Andrew Chase; Nicholas C P Cross
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

6.  Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies.

Authors:  Katrien Van Roosbroeck; Julio Finalet Ferreiro; Thomas Tousseyn; Jo-Anne van der Krogt; Lucienne Michaux; Barbara Pienkowska-Grela; Ivan Theate; Pascale De Paepe; Daan Dierickx; Chantal Doyen; Natalie Put; Jan Cools; Peter Vandenberghe; Iwona Wlodarska
Journal:  Genes Chromosomes Cancer       Date:  2016-02-06       Impact factor: 5.006

7.  Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.

Authors:  T H Davis; C C Morton; R Miller-Cassman; S P Balk; M E Kadin
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

8.  Neutrophilic myelofibrosis presenting as Philadelphia chromosome negative BCR non-rearranged chronic myeloid leukemia.

Authors:  K Stewart; K C Carstairs; I D Dubé; A Keating
Journal:  Am J Hematol       Date:  1990-05       Impact factor: 10.047

Review 9.  Should myeloid and lymphoid neoplasms with PCM1-JAK2 and other rearrangements of JAK2 be recognized as specific entities?

Authors:  Barbara J Bain; Shahzaib Ahmad
Journal:  Br J Haematol       Date:  2014-06-10       Impact factor: 6.998

10.  Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.

Authors:  Stéphane Vignot; Garrett M Frampton; Jean-Charles Soria; Roman Yelensky; Frédéric Commo; Christian Brambilla; Gary Palmer; Denis Moro-Sibilot; Jeffrey S Ross; Maureen T Cronin; Fabrice André; Philip J Stephens; Vladimir Lazar; Vincent A Miller; Elisabeth Brambilla
Journal:  J Clin Oncol       Date:  2013-04-29       Impact factor: 44.544
View more
  2 in total

1.  Molecular Profiling for Proper Diagnosis of Gastroenteropancreatic Neuroendocrine Tumor.

Authors:  Virian D Serei; Elizabeth Poplin; Shridar Ganesan; Gregory Riedlinger
Journal:  JCO Precis Oncol       Date:  2020-07-27

2.  PCM1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.

Authors:  Henry G Kaplan; Ruyun Jin; Carlo B Bifulco; James M Scanlan; David R Corwin
Journal:  Oncologist       Date:  2022-08-05       Impact factor: 5.837
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.